Financials
- Financial year
- 2025
- Total assets
- €2.1m
- Profit
- €296,232
- Solvency
- 27.6%
Total assets▼ 0.8%
Net result
20182025
PHARMA POSITIVE
ActiveSummary
PHARMA POSITIVE has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €576,974 and a net result of €296,232. Equity is growing by about 19% per year across the filed financial years. Its solvency ranks better than 35% of 2,063 sector peers (NACE 73, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
Overview
Activity
Public relations and communication consultancy
NACE 73300Retail sale of pharmaceutical products NACE 47730
1 site
Size
€2.1mtotal assets 2025
- Staff
- 4.4 FTE
- Equity
- €576,974
- Profit
- €296,232
Structure
- Parent
- CC Group · 100%
- Holdings
- 1
2025 accounts 2 days early6 deeds in the Belgian Official Gazette
Why 94lowers riskFigures for financial year 2025 (filed 29-07-2026)Liquidity: current ratio 0.86, cash €457,188Size: 4.4 FTE, total assets €2.1mFounded in 2014Show the evidence
Checked score
Score 2025
94
/ 100
Excellent
Probability in this band: under 0.55%
Financially better than 57% of its sector peers (NACE 73, micro)
Financial strength · tick = 2024
Strong
Solvency
53+14
equity 27.6% of total assets
Liquidity
52+9
short-term debt 50.9% · cash 21.9%
Profitability
86-2
return on assets 14.2%
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
About 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).
Last 24 months
11-2024: 0.1%lowest value
12-2024: 0.1%● unchanged vs 11-2024lowest value
01-2025: 0.1%● unchanged vs 12-2024
02-2025: 0.1%● unchanged vs 01-2025
03-2025: 0.1%● unchanged vs 02-2025
04-2025: 0.1%● unchanged vs 03-2025
05-2025: 0.1%● unchanged vs 04-2025
06-2025: 0.1%● unchanged vs 05-2025
07-2025: 0.2%▲ +0.1 percentage points vs 06-2025
08-2025: 0.4%▲ +0.2 percentage points vs 07-2025
09-2025: 0.3%▼ -0.1 percentage points vs 08-2025
10-2025: 0.3%● unchanged vs 09-2025
11-2025: 0.3%● unchanged vs 10-2025
12-2025: 0.3%● unchanged vs 11-2025
01-2026: 0.3%● unchanged vs 12-2025
02-2026: 0.3%● unchanged vs 01-2026
03-2026: 0.3%● unchanged vs 02-2026
04-2026: 0.3%● unchanged vs 03-2026
05-2026: 0.3%● unchanged vs 04-2026
06-2026: 0.4%▲ +0.1 percentage points vs 05-2026
07-2026: 0.5%▲ +0.1 percentage points vs 06-2026highest value
08-2026: 0.1%▼ -0.4 percentage points vs 07-2026
09-2026: 0.1%● unchanged vs 08-2026
10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €50,000 on 30-day terms is acceptable
Liquidity insufficient (current ratio 0.86, compared with 0.76 in 2024, below 1; short-term debt: 50.9% and cash: 21.9% of total assets), and 72.4% of the assets are financed with debt and provisions.
How it is calculated
The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:
| 75-100 | Excellent | under 0.55% |
| 60-74 | Healthy | 0.55% to 1.5% |
| 45-59 | Fair | 1.5% to 4.2% |
| 25-44 | Weak | 4.2% to 15.0% |
| 0-24 | Critical | over 15.0% |
Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 73, micro): better than 32% on solvency, 42% on liquidity, 63% on profitability and 90% on growth.
The bankruptcy probability was computed on 24-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.
Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).
Credit check for your own amount and term
Show the recommended maximum and see how the verdict changes with amount, term and advance.
Signals
Five signals.
lowers riskneutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-07-2026, 2 days ahead of the deadline.
NBB · 9 filingsDeviation from the deadline
2025
2 days early
2024
20 days late
2023
22 days late
2022
28 days late
2021
18 days early
2020
26 days early
2019
21 days late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 7 accounts on average 6 days after the deadline; the sector median (NACE 73) for financial year 2024 is 6 days before the deadline, and 36% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 20 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven monthsWhere today falls in the filing period
25-10-2026 today31-12-2026 year end31-07-2027 deadline
- Annual accounts filedfinancial year 2025 · abbreviated…
- Equity above €500,000equity €576,974 ▲91.9%
- Annual accounts filedfinancial year 2024 · full…
Key points
- Positive: Equity rose in 2025from €300,742 to €576,974 ▲ 91.9% View
- Positive: Among the best 9% on net resultsector median €16,539 · 2,062 companies €296,232 View
- Positive: 8 profitable years in a rowprofit 2025: €296,232 8 years View
- Controlled by CC Groupthe company in turn controls 1 companies 100% View
By topic
Board & ownership
- Parent
- CC Group · 100%
Network & group
- Subsidiaries
- 1
1 subsidiary
Timeline
- Events
- 18
- Since
- 2015
- Next accounts
- by 31-07-2027
- 31-12-2024Highest result from 2018 to 2025
- 22-08-2024Annual accounts filed
- 28-08-2023Annual accounts filed
Company details
- Sites
- 1
- Legal form
- Private limited company
- Activity
- Public relations and communication consultancyNACE 73300
- Founded
- 07-05-2014
- Year ends
- 31-12
- Peppol
- Reachable for e-invoices
Key facts about PHARMA POSITIVE
- What is the company number of PHARMA POSITIVE?
- 0551.980.676. In Belgium the VAT number is the company number with BE in front: BE 0551.980.676.
- Where is PHARMA POSITIVE based?
- The registered office is at Théodore De Cuyperstraat 165, 1200 Sint-Lambrechts-Woluwe.Company details
- What does PHARMA POSITIVE do?
- According to the KBO register, the main activity is public relations and communication consultancy (NACE 73300).
- What is the legal form of PHARMA POSITIVE?
- Private limited company (BV).
- When was PHARMA POSITIVE founded?
- On 07-05-2014.
- Is PHARMA POSITIVE still active?
- Yes, PHARMA POSITIVE is an active enterprise in the KBO register.
- How many employees does PHARMA POSITIVE have?
- On average 4.4 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
- What is the turnover of PHARMA POSITIVE?
- Not stated in the processed annual accounts. The abridged format for small companies does not require turnover.
- Is PHARMA POSITIVE profitable?
- In financial year 2025, PHARMA POSITIVE made a profit of €296,232.
- Where can I find the annual accounts of PHARMA POSITIVE?
- PHARMA POSITIVE filed 13 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
- When are the next annual accounts of PHARMA POSITIVE due?
- By 31-07-2027, for financial year 2026.Timeline
Companies related to PHARMA POSITIVE
Go further with this company
How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Your own company? See how customers, suppliers and banks see it and what to improve first.
Investigating this company? Keep it with today's facts in a case file.